Dr. Ricardo Restrepo-Jaramillo

Intensive Care Medicine
Univ. Medical Service Association Inc.
2 Tampa General Cir, 
Tampa, FL 
Accepting New Patients
Referral may be required
Before you request
Univ. Medical Service Association Inc.
2 Tampa General Cir, 
Tampa, FL 

Overview

Ricardo Restrepo-Jaramillo is an Intensive Care Medicine provider practicing medicine in Tampa, Florida.

His clinical expertise encompasses Heart Failure with Preserved Ejection Fraction (HFpEF), Systemic Sclerosis (SSc), and Advanced Bronchoscopy.

He is actively involved in clinical research, co-authoring 14 peer reviewed articles and participating in 6 clinical trials. Dr. Restrepo-Jaramillo is currently accepting new patients.

Specialties

Intensive Care Medicine

Licenses

Internal Medicine in FL

Hospital Affiliations

Sarasota Memorial Hospital
Tampa General Hospital
St Anthonys Hospital

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
First Health
  • INSURANCE PLAN
  • MEDICARE PDP
  • PPO
Florida Blue
  • EPO
  • PPO
Freedom Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
Sunshine Health
  • EPO
  • HMO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 18 Less Insurance Carriers -

Locations

Univ. Medical Service Association Inc.
2 Tampa General Cir, Tampa, FL 33606

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by CPET in Subjects With WHO Group 1 Pulmonary Hypertension Who Recently Initiated Therapy
Enrollment Status: Terminated
Publish Date: July 06, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2026
Intervention Type: Drug
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety of Sotatercept Versus Placebo When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy for the Treatment of PAH
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Biological
Study Drug: Sotatercept
Study Phase: Phase 3
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 5 Less Clinical Trials

14 Total Publications

BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension.
BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension.
Journal: Respiratory medicine
Published: June 18, 2025
Similar Doctors
Expertise in
35
conditions
Dr. Domenick J. Sorresso
Intensive Care Medicine | Pulmonary Medicine
Expertise in
35
conditions
Dr. Domenick J. Sorresso
Intensive Care Medicine | Pulmonary Medicine
Referral may be required

C&d Pulmonary PA

7614 Jacque Rd Ste C, 
Hudson, FL 
 (33.8 miles away)
727-857-5967
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Domenick Sorresso is an Intensive Care Medicine specialist and a Pulmonary Medicine provider practicing medicine in Hudson, Florida. Dr. Sorresso is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Cerebral Hypoxia, Gastrostomy, and Advanced Bronchoscopy. Dr. Sorresso is board certified in American Board Of Internal Medicine. Dr. Sorresso is currently accepting new patients.

Expertise in
4
conditions
Dr. Kapilkumar N. Patel
Intensive Care Medicine
Expertise in
4
conditions
Dr. Kapilkumar N. Patel
Intensive Care Medicine
Referral may be required
Before you request

Radiology Associates Of Florida Office

5 Tampa General Cir, 
Tampa, FL 
 (0.1 miles away)
813-844-7137
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kapilkumar Patel is an Intensive Care Medicine provider practicing medicine in Tampa, Florida. Dr. Patel is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Secondary Immunodeficiency (SID), Pulmonary Fibrosis, Systemic Sclerosis (SSc), Gastrostomy, and Bone Marrow Aspiration. Dr. Patel is currently accepting new patients.

Expertise in
19
conditions
Dr. Yatin Kheti
Intensive Care Medicine | Pulmonary Medicine
Expertise in
19
conditions
Dr. Yatin Kheti
Intensive Care Medicine | Pulmonary Medicine
Referral may be required
Before you request

Lakeland Regional Health Systems Inc

3030 Harden Blvd, 
Lakeland, FL 
 (30.0 miles away)
863-284-5050
Experience:
17+ years
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients

Yatin Kheti is an Intensive Care Medicine specialist and a Pulmonary Medicine provider practicing medicine in Lakeland, Florida. He has been practicing medicine for over 17 years. Dr. Kheti is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Pneumonia, Advanced Bronchoscopy, and Gastrostomy. Dr. Kheti is currently accepting new patients.

Frequently Asked Questions about Dr. Ricardo Restrepo-Jaramillo

How do I make an appointment with Dr. Ricardo Restrepo-Jaramillo?

You can book an appointment with Dr. Ricardo Restrepo-Jaramillo by calling their office at 813-259-0619. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ricardo Restrepo-Jaramillo a top-rated expert for Advanced Bronchoscopy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ricardo Restrepo-Jaramillo is classified as an Experienced expert for Advanced Bronchoscopy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ricardo Restrepo-Jaramillo specialize in?

While Dr. Ricardo Restrepo-Jaramillo is a Intensive Care Medicine, they have specific expertise in Advanced Bronchoscopy, Heart Failure with Preserved Ejection Fraction (HFpEF), and Systemic Sclerosis (SSc). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Intensive Care Medicine.

Does Dr. Ricardo Restrepo-Jaramillo participate in research or clinical trials?

Yes. Dr. Ricardo Restrepo-Jaramillo has published 14 articles and abstracts on conditions like Advanced Bronchoscopy. You can view a list of Dr. Ricardo Restrepo-Jaramillo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ricardo Restrepo-Jaramillo accept my insurance?

Dr. Ricardo Restrepo-Jaramillo accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 813-259-0619 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Restrepo-Jaramillo's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile